Particle.news
Download on the App Store
45 ARTICLES
·
6h ago

Tom Brady Says His Dog Is a Clone of Late Family Pet as Colossal Buys Viagen

The disclosure ties Brady’s investment to Colossal’s Viagen acquisition, expanding the biotech’s pet‑cloning push as its de‑extinction claims face dispute.

Fox sports announcer Tom Brady looks on prior to the game between the Philadelphia Eagles and the New York Giants at Lincoln Financial Field on October 26, 2025 in Philadelphia, United States.
Brady, seen here walking his dog Lua in 2013, collected a blood sample to clone her into his new dog, Junie.
Tom Brady looks on from the field during warmups prior to an NFL game between the New York Giants and the Philadelphia Eagles at Lincoln Financial Field on Oct. 26, 2025, in Philadelphia.
Image

Overview

  • Brady said his current dog, Junie, was cloned from his late pit bull mix, Lua, using a blood sample collected before Lua died in December 2023, calling the process non‑invasive.
  • The revelation was coordinated with Colossal Biosciences’ announcement that it acquired Viagen Pets & Equine, consolidating consumer pet‑cloning services under Colossal.
  • Brady is an investor in Colossal and issued his statement through the company, which he credited with giving his family a “second chance” with a clone of their dog.
  • Viagen, now owned by Colossal, is known for cloning celebrity pets and is widely reported to charge about $50,000 for a dog clone, with some estimates up to $85,000.
  • Colossal promotes cloning as a tool for pet owners and conservation, though its claim of breeding dire wolf–like pups has been challenged by groups including the IUCN, and independent validation is not reported in this coverage.